Avid Bioservices Inc (CDMO)

[Fire Fox]

Thank you Mojo-- Great find !!! Confirms everything SK was hinting at during the CC, namely, Roche, BMY and Merck are already very aware of the advantages that will come from combining PD-1 and PD-L1 with Bavi.

Genentech even acknowledges these synergies in a patent application filed Dec. 8, 2009.

If Genentech and Roche anticipated the advantage of combining PD-L1 with Bavi as far back as 2009, it's very believable that when SK said in the CC this week that the immunotherapy studies combining Bavi with PD-L1 and CTLA-4 are "well-advanced", he meant "well-advanced" as in "almost ready for publication."